Synthesis and Screening of Human Monoamine Oxidase-A Inhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives

Loading...
Publication Logo

Date

2015

Authors

Evranos-Aksoz, Begüm
Baysal, İpek
Yabanoğlu-Çiftçi, Samiye
Djikic, Teodora
Yelekçi, Kemal
Uçar, Gülberk
Ertan, Rahmiye

Journal Title

Journal ISSN

Volume Title

Publisher

Wiley-VCH Verlag GmbH

Open Access Color

Green Open Access

No

OpenAIRE Downloads

OpenAIRE Views

Publicly Funded

No
Impulse
Top 10%
Influence
Top 10%
Popularity
Top 10%

Research Projects

Journal Issue

Abstract

A group of 35-diaryl-2-pyrazoline and hydrazone derivatives was prepared via the reaction of various chalcones with hydrazide compounds in ethanol. Twenty original compounds were synthesized. Ten of these original compounds have a pyrazoline structure nine of these original compounds have a hydrazone structure and one of these original compounds has a chalcone structure. Structural elucidation of the compounds was performed by IR H-1 NMR C-13 NMR mass spectral data and elemental analyses. These compounds were tested for their inhibitory activities toward the A and B isoforms of human monoamine oxidase (MAO). Except for 3k and 6c all compounds were found to be competitive reversible and selective inhibitors for either one of the isoforms (hMAO-A or MAO-B). Compounds 3k and 6c were found to be competitive reversible but non-selective MAO inhibitors. Compound 6h showed hMAO-B inhibitory activity whereas the others potently inhibited hMAO-A. Compound 5c showed higher selectivity than the standard drug moclobemide. According to the experimental K-i values compounds 6i 6d and 6a exhibited the highest inhibitory activity toward hMAO-A. The AutoDock 4.2 program was employed to perform automated molecular docking. The calculated results obtained computationally were in good agreement with the experimental values.

Description

Keywords

2-Pyrazoline, Hydrazone, MAO inhibitors, Molecular docking, 2-Pyrazoline, Monoamine Oxidase Inhibitors, Protein Conformation, Moclobemide, Hydrazones, MAO inhibitors, Hydrazone, Molecular Docking Simulation, Kinetics, Structure-Activity Relationship, Drug Design, Molecular docking, Humans, Pyrazoles, Monoamine Oxidase

Fields of Science

0301 basic medicine, 0303 health sciences, 01 natural sciences, 0104 chemical sciences, 03 medical and health sciences, 0302 clinical medicine

Citation

WoS Q

Q2

Scopus Q

Q2
OpenCitations Logo
OpenCitations Citation Count
23

Source

Archiv der Pharmazie

Volume

348

Issue

10

Start Page

743

End Page

756
PlumX Metrics
Citations

CrossRef : 20

Scopus : 27

PubMed : 2

Captures

Mendeley Readers : 27

SCOPUS™ Citations

27

checked on Feb 11, 2026

Web of Science™ Citations

21

checked on Feb 11, 2026

Page Views

3

checked on Feb 11, 2026

Downloads

123

checked on Feb 11, 2026

Google Scholar Logo
Google Scholar™
OpenAlex Logo
OpenAlex FWCI
1.08430063

Sustainable Development Goals

SDG data is not available